Reset filter
Keywords
Osteoporosis ×
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

9 Search results.

Relevance Rating New first Old first

Eligibility NCT00332709 Osteoporosis. Postmenopausal - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 15 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00332709

Eligibility Osteoporosis NCT00467285

- 9/20/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Effect of Diabetic Medications on Bone Metabolism; ODM derived from: https://clinicaltrials.gov/show/NCT00467285

Eligibility Osteoporosis NCT00703417

- 9/20/21 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT00703417

Eligibility Osteoporosis NCT02484131

- 6/5/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Bone Health Management for Women Diagnosed With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02484131

Eligibility Osteoporosis NCT02429232

- 6/5/19 - 1 form, 2 itemgroups, 25 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
A One-year Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Mineral Density; ODM derived from: https://clinicaltrials.gov/show/NCT02429232

Eligibility Bone Loss NCT00485953

- 7/6/17 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00485953

Eligibility Prevent Osteoporosis and Osteoporotic Fractures NCT00639210

- 6/6/17 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Criteria,Exclusion Criteria
BREAST CANCER AND EXERCISE; ODM derived from: https://clinicaltrials.gov/show/NCT00639210

Eligibility Osteoporosis NCT00411190

- 5/28/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin; ODM derived from: https://clinicaltrials.gov/show/NCT00411190

Eligibility Bone Loss NCT00171340

- 7/4/16 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00171340

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial